Tangible Shareholders Equity (Annual)

Tangible Shareholders Equity: The value shareholders equity less intangible assets.

ARS Pharmaceuticals, Inc. (SPRY) had Tangible Shareholders Equity of $99.81M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$84.28M
Net Income	$-171.39M
Cost of Goods Sold	$20.42M
Gross Profit	$63.85M
Operating Expenses	$263.73M
Operating Income	$-179.45M
Non-Operating Income/Expense	$8.07M
Pre-Tax Income	$-171.38M
Normalized Pre-Tax Income	$-171.38M
Income after Taxes	$-171.30M
Income from Continuous Operations	$-171.30M
Consolidated Net Income/Loss	$-171.30M
Normalized Income after Taxes	$-171.30M
EBIT	$-179.45M
EBITDA	$-183.60M
Weighted-Average Shares Outstanding (Basic)	98.57M
Weighted-Average Shares Outstanding (Diluted)	98.57M
Earnings per Share (EPS) (Basic)	$-1.74
Earnings per Share (EPS) (Diluted)	$-1.74
Balance Sheet Financials
Current Assets	$284.90M
Property, Plant, and Equipment	$2.46M
Long-Term Assets	$42.76M
Total Assets	$327.65M
Current Liabilities	$39.15M
Long-Term Debt	$168.51M
Long-Term Liabilities	$174.25M
Total Liabilities	$213.39M
Common Equity	$114.26M
Tangible Shareholders Equity	$99.81M
Shareholders Equity	$114.26M
Common Shares Outstanding	99.29M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-170.87M
Cash Flow from Investing Activities	$56.77M
Cash Flow from Financial Activities	$104.60M
Beginning Cash	$50.82M
End Cash	$41.32M
Increase/Decrease in Cash	$-9.50M
Stock-Based Compensation	$22.09M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.28
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.60
Debt to Equity Ratio	1.47
Gross Margin	75.77%
Operating Margin	-212.92%
EBIT Margin	-212.92%
EBITDA Margin	-217.86%
Pre-Tax Profit Margin	-203.35%
Profit Margin	-203.37%
Free Cash Flow	$-171.21M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	2.44
Receiveable Turnover	3.33
Days Sales in Receivables	109.78
Return on Equity	-149.92%
Return on Tangible Equity	-171.63%
Return on Assets	-52.28%
Return on Investments	-60.58%
Book Value Per Share	$1.15
Free Cash Flow per Share	$-1.74
Operating Cash Flow per Share	$-1.73

Data from Zacks Investment Research, Inc.